Tag: artificial lung market scope

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Artificial Lung Market Poised To Hit $4.27 Billion By 2030 With A 10.4% CAGR

The artificial lung market has seen substantial growth in recent times. Its valuation is expected to climb from $2.58 billion in 2025 to $2.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be attributed to several factors, including an increase in acute respiratory failure cases, the early incorporation of heart-lung machines in cardiothoracic operations, a rise in organ transplant procedure volumes, the evolution of membrane artificial lung technology, and the expanding application of extracorporeal life support systems.

The artificial lung market size is expected to experience substantial growth in the next few years. It is projected to reach $4.27 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.4%. The anticipated expansion during the forecast period can be attributed to an increasing need for critical care life-support devices, a growing emphasis on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, the expansion of applications within emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Key trends during this period include a surging demand for artificial lung systems in cases of severe respiratory failure and critical care management, the rising utilization of extracorporeal support devices in intricate cardiac and lung transplant surgeries, a growing inclination towards minimally invasive and temporary lung support options as alternatives to transplantation, the increasing development of portable and transport-compatible artificial lung units for emergency care settings, and the expanding deployment of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=26165209&type=smp&name=Artificial%20Lung%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Artificial Lung Market Industry Drivers: What’s Behind The Revenue Growth?

The artificial lung market is expected to expand in the future due to the increasing incidence of respiratory ailments. The rise in respiratory diseases is attributed to a combination of factors, including growing air pollution, climate change, and evolving lifestyle habits, all of which contribute significantly to public health concerns. Artificial lungs are utilized in these conditions to provide oxygenation and remove carbon dioxide from the blood, either supporting or replacing compromised lung function. For example, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, estimated that approximately 8.5 million people in Australia, or 34% of the population, had chronic respiratory conditions. This included an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is driving the expansion of the artificial lung market.

Artificial Lung Market Segment Analysis Spotlighting Growth Areas

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

#Artificial Lung Market Growth Trends: What’s Shaping The Future Outlook?

Leading companies within the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, to broaden extracorporeal life support beyond the ICU and facilitate quick transport and deployment in the field. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to deliver extracorporeal oxygenation and circulatory assistance, without relying on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, reported that MOBYBOX, the world’s first integrated portable pneumatic ECMO system, had finished its initial commercial applications in Europe; MOBYBOX weighs about 2.5 kg, is powered solely by the oxygen supply, allowing it to function without a battery or motor, incorporates Bionique Flow Technology for softer blood handling and better gas exchange, and has obtained Medical Device Regulation certification for its introductory markets.

Artificial Lung Market Key Participants And Competitive Landscape

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB‑Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

View The Full Artificial Lung Market Report:

https://thebusinessresearchcompany.com/report/artificial-lung-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Artificial Lung Market Geographic Analysis: Where Is Demand Accelerating Fastest?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Artificial Lung Market Compare Between 2026 And 2030?

The artificial lung market has experienced substantial expansion in recent years. Projections indicate its value will increase from $2.58 billion in 2025 to $2.88 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to its historical growth include the escalating occurrence of acute respiratory failure, the swift integration of heart-lung machines in cardiothoracic operations, an increase in organ transplant procedures, advancements in membrane artificial lung technology, and the expanding application of extracorporeal life support systems.

The artificial lung market size is expected to experience significant expansion in the coming years, with projections indicating it will reach $4.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.4%. This anticipated growth can be attributed to factors such as the increasing demand for critical care life-support devices, a growing emphasis on portable and compact artificial lung systems, rising investments in advanced oxygenation membrane materials, the expansion of their applications in emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Key trends influencing this period include the escalating demand for artificial lung systems for severe respiratory failure and critical care management, the rising utilization of extracorporeal support devices in complex cardiac and lung transplant surgeries, a growing preference for minimally invasive and temporary lung support alternatives over transplantation, the increasing development of portable and transport-compatible artificial lung units for emergency settings, and the expanding use of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

What Influential Factors Are Boosting The Artificial Lung Market Demand?

The rising occurrence of respiratory ailments is projected to advance the artificial lung market’s expansion. This increase in respiratory disease prevalence arises from several factors, including escalating air pollution, shifting climate patterns, and evolving lifestyle choices, which place a considerable burden on public health. Artificial lungs play a crucial role in managing respiratory conditions by delivering oxygen and extracting carbon dioxide from the bloodstream, thereby supporting or substituting compromised lung function. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that roughly 8.5 million people in Australia, representing 34% of the population, were estimated to be affected by chronic respiratory conditions. This figure encompasses an estimated 2.8 million people, or 11% of the population, suffering from asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Consequently, the growing incidence of respiratory diseases is propelling the artificial lung market forward.

Which Segment Groups Define The Artificial Lung Market Landscape?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

What Trends Are Affecting The Growth Of The Artificial Lung Market?

Major companies operating in the artificial lung market are prioritizing the creation of innovative solutions, including truly portable pneumatic ECMO systems, to expand extracorporeal life support beyond the ICU and enable rapid transport and field deployment. A pneumatic portable ECMO system utilizes oxygen-supply-driven pneumatic pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without depending on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, which is the world’s first integrated portable pneumatic ECMO system, completed its initial commercial applications in Europe. MOBYBOX weighs about 2.5 kg, is solely driven by the oxygen supply, allowing it to operate without a battery or motor, features Bionique Flow Technology for gentler blood handling and improved gas exchange, and has obtained Medical Device Regulation certification for initial markets.

Who Are The Firms Contributing To The Artificial Lung Market Ecosystem?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Access The Complete Artificial Lung Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Which Region Accounts For The Highest Share Of The Artificial Lung Market?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Lung Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Artificial Lung Market Between 2026 And 2030?

The artificial lung market has seen swift growth over recent years. This market is expected to increase from $2.58 billion in 2025 to $2.88 billion in 2026, indicating a compound annual growth rate (CAGR) of 11.6%. The historical expansion of this market can be linked to several factors, including an increase in acute respiratory failure incidents, the early integration of heart lung machines into cardiothoracic surgery, a rise in the number of organ transplant procedures, the evolution of membrane artificial lung technology, and the growing application of extracorporeal life support systems.

The artificial lung market is anticipated to experience significant growth in the coming years. This market is projected to reach $4.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%. The expansion during the forecast period is attributed to an increasing demand for critical care life-support devices, a growing focus on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, a broader application in emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Major trends expected in this period include a heightened demand for artificial lung systems in severe respiratory failure and critical care management, the rising use of extracorporeal support devices in complex cardiac and lung transplant surgeries, a developing preference for minimally invasive and temporary lung support alternatives to transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care settings, and the expanding utilization of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Which Strong Drivers Are Impacting The Artificial Lung Market Growth?

The rising incidence of respiratory diseases is projected to spur the growth of the artificial lung market in the coming years. The increased prevalence of these conditions is attributed to a confluence of factors such as escalating air pollution, climate change, and shifts in lifestyle, imposing a substantial burden on public health. Artificial lungs play a crucial role in treating respiratory diseases by facilitating oxygenation and removing carbon dioxide from the bloodstream, thereby assisting or replacing compromised lung function. As an illustration, figures from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, estimated that approximately 8.5 million people in Australia, or 34% of the population, suffered from chronic respiratory conditions. This total included an estimated 2.8 million people, or 11% of the population, battling asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the escalating prevalence of respiratory diseases is directly fueling the expansion of the artificial lung market.

What Segment Categories Shape The Artificial Lung Market Segment Landscape?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

Which Trends Are Contributing To Changes In The Artificial Lung Market?

Major companies in the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, to broaden extracorporeal life support capabilities beyond the ICU and enable rapid transport and deployment in diverse settings. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to deliver extracorporeal oxygenation and circulatory support without needing external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a medical device company based in Germany, declared that MOBYBOX, known as the world’s first integrated portable pneumatic ECMO system, had successfully concluded its initial commercial applications in Europe; MOBYBOX weighs approximately 2.5 kg, functions entirely on oxygen supply thus requiring no battery or motor, incorporates Bionique Flow Technology for milder blood handling and better gas exchange, and has secured Medical Device Regulation certification for its early markets.

Who Are The Companies Operating Across The Artificial Lung Market Value Chain?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Get The Full Artificial Lung Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Which Region Leads The Artificial Lung Market In Overall Market Size?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Lung Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Artificial Lung Market During The Forecast Period 2026–2030?

The artificial lung market has experienced significant expansion recently. Its size is expected to climb from $2.58 billion in 2025 to $2.88 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.6%. This market’s historical growth can be attributed to factors such as an increase in acute respiratory failure cases, the early adoption of heart-lung machines in cardiothoracic surgery, a rise in organ transplant procedure volumes, the progression of membrane artificial lung technology, and the growing utilization of extracorporeal life support systems.

The artificial lung market is anticipated to experience substantial growth in the coming years. It is projected to reach $4.27 billion in 2030, showing a compound annual growth rate (CAGR) of 10.4%. This projected expansion can be attributed to several factors, including the rising need for critical care life-support devices, a heightened focus on portable and compact artificial lung systems, increased investment in advanced oxygenation membrane materials, the broadening scope of applications in emergency and trauma care, and the greater embrace of minimally invasive extracorporeal support solutions. Significant trends during this forecast period involve an escalating demand for artificial lung systems in severe respiratory failure and critical care management, the increasing adoption of extracorporeal support devices in intricate cardiac and lung transplant surgeries, a developing preference for minimally invasive and temporary lung support alternatives to transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care environments, and the expanding utilization of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Which Economic Or Industry Drivers Are Impacting The Artificial Lung Market?

The increasing incidence of respiratory ailments is projected to propel the expansion of the artificial lung market moving forward. The growing prevalence of respiratory diseases results from a combination of factors, including escalating air pollution, climate change, and lifestyle modifications, which collectively place a significant burden on public health. Artificial lungs are utilized in respiratory conditions to ensure oxygenation and remove carbon dioxide from the blood, thereby assisting or replacing compromised lung function. For example, in June 2024, data from the Australian Institute of Health and Welfare, a health and welfare agency based in Australia, indicated that an estimated 8.5 million people in Australia, equating to 34% of the population, were living with chronic respiratory conditions. This total included approximately 2.8 million people, or 11% of the population, diagnosed with asthma, and 638,000 individuals, or 2.5% of the population, affected by chronic obstructive pulmonary disease (COPD). Hence, the rising occurrence of respiratory diseases is stimulating the growth of the artificial lung market.

What Market Segments Are Evaluated Within The Artificial Lung Market?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

What Industry Trends Are Redefining The Artificial Lung Market?

Leading firms within the artificial lung market are concentrating on developing innovative solutions, such as genuinely portable pneumatic ECMO systems, to extend extracorporeal life support beyond the ICU and facilitate rapid transport and field deployment. Such pneumatic portable ECMO systems operate using oxygen-supply-driven pneumatic pumps and integrated gas management, providing extracorporeal oxygenation and circulatory support without requiring external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, recognized as the world’s inaugural integrated portable pneumatic ECMO system, successfully completed its initial commercial applications in Europe. MOBYBOX weighs approximately 2.5 kg, functions solely by its oxygen supply thus operating without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and improved gas exchange, and has secured Medical Device Regulation certification for its initial markets.

Who Are The Top Market Participants Influencing The Artificial Lung Market?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB‑Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Read the full artificial lung market report here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

What Are The Top-Performing Regions Within The Artificial Lung Market?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Lung Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the fin field-effect transistor (finfet) 3d transistors market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Artificial Lung Market reach by 2030 starting from 2026 levels?

The artificial lung market has experienced significant growth over recent years. It is projected to expand from $2.58 billion in 2025 to reach $2.88 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. Historically, this expansion can be attributed to several factors, including a rise in the incidence of acute respiratory failure cases, the early adoption of heart lung machines in cardiothoracic surgery, increased volumes of organ transplant procedures, advancements in membrane artificial lung technology, and the growing utilization of extracorporeal life support systems.

The artificial lung market is anticipated to experience substantial growth over the next few years, with projections indicating a rise to $4.27 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.4%. This expansion during the forecast period is driven by factors such as an escalating demand for critical care life-support devices, an increased focus on developing portable and compact artificial lung systems, greater investment in advanced oxygenation membrane materials, the broadening of applications in emergency and trauma care, and the expanding adoption of minimally invasive extracorporeal support solutions. Noteworthy trends for this period include an uptick in demand for artificial lung systems in instances of severe respiratory failure and critical care management, increased utilization of extracorporeal support devices in complex cardiac and lung transplant surgeries, a rising preference for minimally invasive and temporary lung support alternatives to traditional transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care settings, and the wider deployment of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Which Drivers Are Influencing Long-Term Growth In The Artificial Lung Market?

The artificial lung market is projected to expand, driven by the increasing occurrence of respiratory conditions. The rise in these diseases is attributed to various elements, including heightened air pollution, shifts in climate, and evolving lifestyle patterns, which impose a substantial burden on public health. Artificial lungs serve to aid individuals with respiratory ailments by providing necessary oxygenation and removing carbon dioxide from the blood, either assisting or substituting impaired lung function. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that roughly 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This data included an estimated 2.8 million individuals, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, affected by chronic obstructive pulmonary disease (COPD). Consequently, the growing prevalence of respiratory diseases is a primary catalyst for the expansion of the artificial lung market.

Which Segments Are Driving Activity In The Artificial Lung Market?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

Which Trends Are Expected To Influence The Artificial Lung Market In The Upcoming Years?

Major companies operating in the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, with the aim of expanding extracorporeal life support beyond the ICU and facilitating rapid transport and field deployment. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without relying on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, identified as the world’s first integrated portable pneumatic ECMO system, had completed its initial commercial applications in Europe; MOBYBOX weighs about 2.5 kg, is exclusively driven by the oxygen supply, allowing it to function without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and improved gas exchange, and has secured Medical Device Regulation certification for its initial markets.

Which Key Players Are Driving Competition In The Artificial Lung Market?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Which Region Is Projected To Lead The Artificial Lung Market During The Forecast Period?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Lung Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial lung market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Artificial Lung Market By The End Of 2029?

The artificial lung market has seen substantial expansion in recent times. Its value is expected to rise from $2.31 billion in 2024 to $2.58 billion in 2025, at a compound annual growth rate (CAGR) of 11.6%. This historical growth can be linked to heightened awareness among medical professionals, broader market reach, expanded applications in home care settings, an increase in medical tourism, and advancements in healthcare infrastructure.

The artificial lung market is projected to experience substantial expansion in the coming years. It is anticipated to grow to $3.91 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.0%. This growth during the forecast period is primarily attributed to the increasing prevalence of respiratory diseases, enhancements in healthcare facilities, the rising acceptance of minimally invasive procedures, improvements in patient quality of life, and the growing incidence of chronic obstructive pulmonary diseases. Key trends expected in the forecast period include the integration of wireless technology, the incorporation of artificial intelligence (AI), advancements in genomics and medical technology, and the development of more compact and portable artificial lungs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Which Business Drivers Are Underpinning The Growth Of The Artificial Lung Market?

The growth of the artificial lung market is projected to be propelled by the escalating prevalence of respiratory diseases moving forward. The rising incidence of these conditions is attributed to various factors, including heightened air pollution, climate change, and shifts in lifestyle, all of which impose a significant burden on public health. Artificial lungs are employed in respiratory diseases to provide oxygenation and remove carbon dioxide from the blood, thereby supporting or replacing impaired lung function. For instance, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, revealed that approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This figure included an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). Consequently, the increasing prevalence of respiratory diseases is driving the expansion of the artificial lung market.

What Are The Principal Segment Types In The Artificial Lung Market?

The artificial lungmarket covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

How Are Industry Trends Steering The Expansion Of The Artificial Lung Market?

Major companies in the artificial lung market are concentrating on creating advanced solutions, particularly involving the remote oversight and operation of devices, to achieve a competitive advantage. This approach enables healthcare providers to track patients’ essential parameters and modify ventilation settings without requiring physical presence, thus lowering infection dangers and improving patient well-being during care. An example occurred in August 2022, when Teltonika Telemedic, an electronics producer from the US, made notable strides in developing its artificial lung ventilator, designated TELTOMED. Teltonika Telemedic has obtained an exclusive patent for the secure remote transfer and management of its ventilator’s data. This technology boosts the safety and dependability of patient data exchange, which is a vital attribute for contemporary medical equipment.

Which Companies Are Contributing Significantly To The Artificial Lung Market Growth?

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomédica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Which Region Offers The Most Opportunity For Artificial Lung Market Expansion?

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2025, By The Business Research Company

Artificial Organ Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Artificial Organ And Bionics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-organ-and-bionics-global-market-report

Synthetic Leather Or Artificial Leather Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-leather-or-artificial-leather-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Artificial Lung Market From 2025 To 2029?

The size of the artificial lung market has experienced a brisk increase in the past few years. It is anticipated to expand from $2.31 billion in 2024 to $2.58 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.6%. This substantial growth seen in the historical period can be credited to factors such as increased awareness among healthcare practitioners, escalated market penetration, a surge in applications within the home care setting, growth in medical tourism, and enhancements in healthcare facilities.

In the upcoming years, there is an anticipated rapid expansion in the market size of artificial lungs. By 2029, this market is projected to attain a value of $3.91 billion, with a compound annual growth rate (CAGR) of 11.0%. This increase during the forecasted period can be credited to factors such as the escalating frequency of respiratory ailments, augmentation in healthcare amenities, rising adoption of minimally invasive techniques, improved patient life quality, and increased frequency of chronic obstructive pulmonary diseases. The period’s significant trends comprise the incorporation of wireless technology and artificial intelligence (AI), breakthroughs in genomics and medical technology, along with the creation of smaller, more transportable artificial lungs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

What External and Internal Drivers Are Contributing to the Growth of theArtificial Lung Market?

The surge in occurrences of respiratory illnesses is anticipated to drive the growth of the artificial lung market. The escalating incidence of these diseases can be attributed to a mixture of causes such as increasing air contamination, climate alterations, and changes in lifestyle, leading to a considerable strain on public health. Artificial lungs are predominantly used in treating respiratory illnesses by supplying oxygen and eliminating carbon dioxide from the blood, thereby supplementing or substituting the impaired lung functionality. For instance, as per the data released by the Australian Institute of Health and Welfare in June 2024, an Australia-based health welfare agency, roughly 8.5 million people, equivalent to 34% of the Australian population, had chronic respiratory disorders. These figures include nearly 2.8 million people or 11% of the population affected by asthma, along with 638,000 individuals, making up 2.5% of the population, suffering from chronic obstructive pulmonary disease (COPD). Therefore, the escalating occurrences of respiratory illnesses are catalyzing the expansion of the artificial lung market.

What Segment Types Define the Artificial Lung Market Structure?

The artificial lungmarket covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Artificial Lung Market?

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Artificial Lung Market?

Key players in the artificial lung market are honing their competitive advantage by focusing on the creation of innovative solutions, such as remote device monitoring and control. This technology empowers medical practitioners to track patient vital statistics and alter ventilator settings without necessitating their physical presence at the patient’s bedside. This not only diminishes infection risk, but also heightens patient safety throughout the treatment process. For instance, in August 2022, a notable advancement was made by US-based electronics manufacturing company, Teltonika Telemedic, in the development of their artificial lung ventilator known as TELTOMED. They have obtained an exclusive patent for secure data transmission and control of the ventilator remotely, thus enhancing data security and reliability, which are crucial aspects for contemporary medical appliances.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

What Is the Definition of the Artificial Lung Market?

An artificial lung refers to a medical device designed to take over the function of natural lungs, providing oxygen to the blood and removing carbon dioxide. It is typically used in patients with severe respiratory failure or during surgeries that require the heart and lungs to be temporarily non-functional. This technology aims to support or replace lung function, allowing patients to survive and recover from critical conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16591

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Artificial Lung Market Expected to Grow Between 2025 And 2029?

The market size of artificial lungs has seen a staggering increase in recent years. The market, which is predicted to surge from $2.31 billion in 2024 to $2.59 billion in 2025, is anticipated to have a compound annual growth rate (CAGR) of 12.2%. Factors such as enhanced awareness among healthcare practitioners, augmented market infiltration, a rise in usage in home care scenarios, a boost in medical tourism, and advancements in healthcare facilities have all contributed to the growth experienced in the historic period.

What Growth Rate Is Anticipated for the Artificial Lung Market in the Coming Years?

Over the upcoming years, the artificial lung market size is projected to expand rapidly, reaching $4.06 billion in 2029 with an 11.9% compound annual growth rate (CAGR). The anticipated growth during this period is tied to the increasing number of respiratory disease cases, advancements in healthcare facilities, growing popularity of minimally invasive procedures, improved patient quality of life, and high prevalence of chronic obstructive pulmonary diseases. Noteworthy trends for this period encompass inclusion of wireless technology, incorporation of artificial intelligence (AI), advancements in genomics and medical technology, and the creation of smaller, more transportable artificial lungs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

Who Are the Leading Companies in the Artificial Lung Market?

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomédica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

What Are the Key Drivers of the Artificial Lung Market?

The escalating occurrence of respiratory ailments is projected to be a major growth catalyst for the artificial lung market in the future. Such disease prevalence is rising as a result of various factors such as increasing air contamination, climate alterations, and lifestyle transformations, all of which pose a considerable impact on public health. Artificial lungs, used in respiratory illnesses to provide oxygenation and eliminate carbon dioxide from the bloodstream, support or replace the functionality of compromised lungs. As a case in point, data from the Australian Institute of Health and Welfare in June 2024 revealed that about 8.5 million individuals in Australia, equivalent to 34% of the population, were believed to be suffering from chronic respiratory conditions. This consisted of an estimated 2.8 million individuals or 11% of the populace, coping with asthma, and 638,000 individuals or 2.5% of the populace managing chronic obstructive pulmonary disease (COPD). Consequently, the escalation in respiratory disease incidence is fueling the expansion of the artificial lung market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

What Are the Key Market Segments in the Artificial Lung Industry?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

What Are the Latest Trends in the Artificial Lung Market?

Leading firms in the artificial lung market are honing their competitive edges by concentrating on the creation of novel solutions like remote monitoring and device control. This tech-savvy approach enables health practitioners to oversee patients’ primary health metrics and manipulate ventilator preferences without the necessity of physical proximity, minimising infection hazards and heightening patient safety during therapy. For example, in August 2022, Teltonika Telemedic, an electronics production company based in the US, made notable strides in the advancement of its artificial lung ventilator called TELTOMED. The company also secured a distinct patent for the secure transmission and control of remote data for its ventilator, enhancing the security and dependability of patient data exchange, which is a key aspect in today’s medical devices.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

What Are the Key Regional Markets in the Artificial Lung Industry?

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16591

This Report Delivers Insight On:

1. How big is the artificial lung market, and how is it changing globally?

2. Who are the major companies in the artificial lung market, and how are they performing?

3. What are the key opportunities and risks in the artificial lung market right now?

4. Which products or customer segments are growing the most in the artificial lung market?

5. What factors are helping or slowing down the growth of the artificial lung market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the artificial lung industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Artificial Lung Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the artificial lung market has seen sharp increases in its size. Projected growth is expected to take the market from $2.31 billion in 2024 to $2.59 billion the following year, with a CAGR standing at 12.2%. The various reasons that have fueled this growth include enhanced understanding among healthcare professionals, broader market reach, more applications in domestic healthcare settings, a surge in medical tourism, and advancements in healthcare facilities.

In the coming years, the artificial lung market is anticipated to experience considerable expansion. By 2029, the market size is expected to rise to $4.06 billion, with an compound annual growth rate (CAGR) of 11.9%. The projected increase during this period can be related to the growing incidence of respiratory disorders, advancements in healthcare amenities, increasing adoption of minimally invasive treatments, improved patient life quality, and elevated chronic obstructive pulmonary disease prevalence. Noteworthy trends for the forecast period are the inclusion of wireless technology, integration of artificial intelligence (AI), progression in genomics and medical tech, and creation of compact and transportable artificial lungs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

What Are the Core Market Drivers Propelling Growth in the Artificial Lung Industry?

Rising instances of respiratory ailments are projected to stimulate the expansion of the artificial lung industry in the future. Factors such as escalating levels of air pollution, climate variations, and shifts in lifestyle are contributing to the growth in respiratory diseases, which in turn, exert significant pressure on public healthcare systems. Artificial lungs, used to support or replace compromised lung function by providing oxygen and removing carbon dioxide from blood, play a key role in the treatment of these conditions. For example, data from the Australian Institute of Health and Welfare, a health and welfare organization based in Australia, showed that around 8.5 million individuals or 34% of Australia’s population were suffering from chronic respiratory diseases in June 2024. The affected demographic includes an estimated 2.8 million individuals or 11% of the population with asthma, and approximately 638,000 individuals or 2.5% of the population with Chronic Obstructive Pulmonary Disease (COPD). Consequently, the surge in respiratory diseases is influencing the growth of the artificial lung industry.

How Is the Artificial Lung Market Segmented?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Which Regions Are Driving the Next Phase of the Artificial Lung Market Growth?

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Artificial Lung Industry?

Leading corporations within the artificial lung market are concentrating their efforts on creating innovative solutions, for example, the implementation of remote monitoring and control systems, in order to secure a competitive advantage. This arrangement enables health professionals to oversee patients’ key readings and tweak ventilation settings without the necessity to be in physical proximity to the patient’s bed, thereby diminishing infection risk and boosting patient safety during their treatment. For example, in August 2022, Teltonika Telemedic, a electronics manufacturer based in the US, made significant headway in the creation of its artificial lung ventilator, known as TELTOMED. Teltonika Telemedic has obtained an exclusive patent for this secure remote data transmission and control of its ventilator. This technological advancement heightens the security and dependability of patient data communications, which is a crucial aspect of contemporary medical equipment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

How Is the Artificial Lung Market Defined and What Are Its Core Parameters?

An artificial lung refers to a medical device designed to take over the function of natural lungs, providing oxygen to the blood and removing carbon dioxide. It is typically used in patients with severe respiratory failure or during surgeries that require the heart and lungs to be temporarily non-functional. This technology aims to support or replace lung function, allowing patients to survive and recover from critical conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16591

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model